Marina V. Shestakova

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

W. Timothy Garvey, Juan P. Frías, Ania M. Jastreboff et al. · The Lancet · 2023 · 590 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +6

Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 9th edition

Marina V. Shestakova, Olga K. Vikulova, G. R. Galstyan et al. · Diabetes Mellitus · 2019 · 255 citations · Full text

Family Medicine, Russian Federation, Logistic Analysis +19

The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)

Marina V. Shestakova, G. R. Galstyan · Diabetes Mellitus · 2016 · 251 citations · Full text

Metabolic Syndrome, Nation Study, Diabetes Management +14

Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022

Marina V. Shestakova, Olga K. Vikulova, Anna V. Zheleznyakova et al. · Diabetes Mellitus · 2023 · 217 citations · Full text

Russian Federation, Metabolic Syndrome, Type 1 +16

Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 10th edition

Marina V. Shestakova, Alexander Yu. Mayorov, Natalya G. Mokrysheva et al. · Diabetes Mellitus · 2022 · 196 citations · Full text

Russian Federation, Mayorov A.yu, Metabolic Syndrome +19